Nilsine Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $735K | Sell |
1,889
-42
| -2% | -$16.3K | 0.07% | 224 |
|
|
2025
Q1 | $840K | Buy |
1,931
+93
| +5% | +$40.5K | 0.09% | 200 |
|
|
2024
Q4 | $678K | Sell |
1,838
-298
| -14% | -$110K | 0.07% | 217 |
|
|
2024
Q3 | $1.11M | Sell |
2,136
-128
| -6% | -$66.5K | 0.14% | 165 |
|
|
2024
Q2 | $1.23M | Buy |
2,264
+12
| +0.5% | +$6.5K | 0.16% | 149 |
|
|
2024
Q1 | $1.17M | Buy |
2,252
+701
| +45% | +$364K | 0.16% | 154 |
|
|
2023
Q4 | $731K | Buy |
1,551
+48
| +3% | +$22.6K | 0.11% | 193 |
|
|
2023
Q3 | $654K | Sell |
1,503
-23
| -2% | -$10K | 0.1% | 196 |
|
|
2023
Q2 | $678K | Sell |
1,526
-84
| -5% | -$37.3K | 0.1% | 201 |
|
|
2023
Q1 | $740K | Buy |
+1,610
| New | +$740K | 0.12% | 186 |
|